Literature DB >> 26140093

Non-alcoholic fatty liver disease and beneficial effects of dietary supplements.

Ludovico Abenavoli1.   

Abstract

I read with great interest the review published by Eslamparast et al, on the dietary supplements with hepato-protective properties, and their proposed mechanisms to protect against non-alcoholic fatty liver disease. In this way, recently, our study group reported the efficacy of the Mediterranean diet associated to an antioxidant complex, to improve in overweight patients not only anthropometric parameters, but also insulin-resistance, lipid serum levels, and intra-hepatic fat accumulation.

Entities:  

Keywords:  Antioxidant; Mediterranean diet; Metabolic syndrome; Milk thistle; Non-alcoholic fatty liver disease

Year:  2015        PMID: 26140093      PMCID: PMC4483555          DOI: 10.4254/wjh.v7.i12.1723

Source DB:  PubMed          Journal:  World J Hepatol


  6 in total

1.  The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Anna Mae Diehl; Elizabeth M Brunt; Kenneth Cusi; Michael Charlton; Arun J Sanyal
Journal:  Gastroenterology       Date:  2012-05-15       Impact factor: 22.682

Review 2.  Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease.

Authors:  Tannaz Eslamparast; Sareh Eghtesad; Hossein Poustchi; Azita Hekmatdoost
Journal:  World J Hepatol       Date:  2015-02-27

Review 3.  From NAFLD in clinical practice to answers from guidelines.

Authors:  Fabio Nascimbeni; Raluca Pais; Stefano Bellentani; Christopher Paul Day; Vlad Ratziu; Paola Loria; Amedeo Lonardo
Journal:  J Hepatol       Date:  2013-06-07       Impact factor: 25.083

Review 4.  What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?

Authors:  Giovanni Tarantino; Carmine Finelli
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

5.  Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease.

Authors:  Ludovico Abenavoli; Marta Greco; Immacolata Nazionale; Valentina Peta; Natasa Milic; Francesca Accattato; Daniela Foti; Elio Gulletta; Francesco Luzza
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-01-23       Impact factor: 3.869

Review 6.  Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet.

Authors:  Ludovico Abenavoli; Natasa Milic; Valentina Peta; Francesco Alfieri; Antonino De Lorenzo; Stefano Bellentani
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

  6 in total
  5 in total

1.  Resistant Maltodextrin Ameliorates Altered Hepatic Lipid Homeostasis via Activation of AMP-Activated Protein Kinase in a High-Fat Diet-Fed Rat Model.

Authors:  Shing-Hwa Liu; Chen-Yuan Chiu; Lin-Hui Huang; Meng-Tsan Chiang
Journal:  Nutrients       Date:  2019-01-29       Impact factor: 5.717

Review 2.  Beyond Body Weight-Loss: Dietary Strategies Targeting Intrahepatic Fat in NAFLD.

Authors:  Nicolai Worm
Journal:  Nutrients       Date:  2020-05-06       Impact factor: 5.717

3.  Complementary and alternative therapies for non-alcoholic fatty liver disease: A Bayesian network meta-analysis protocol.

Authors:  Tiefeng Zhang; Duan Han; Tianqi Zhang; Cai Jing; Jianguang Sun
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

Review 4.  Nutrition and Physical Activity in Nonalcoholic Fatty Liver Disease.

Authors:  Claudia P Oliveira; Priscila de Lima Sanches; Erlon Oliveira de Abreu-Silva; Aline Marcadenti
Journal:  J Diabetes Res       Date:  2015-12-07       Impact factor: 4.011

Review 5.  Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease.

Authors:  Guanliang Chen; Yinhua Ni; Naoto Nagata; Liang Xu; Tsuguhito Ota
Journal:  Int J Mol Sci       Date:  2016-08-23       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.